Is the prevalence of thyroid disease higher in children receiving antiepileptic medication? A systematic review and meta-analysis.
Title | Is the prevalence of thyroid disease higher in children receiving antiepileptic medication? A systematic review and meta-analysis. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Ilia, T. Soultana, Dragoumi P., Papanikolopoulou S., Goulis D. G., Pavlou E., & Zafeiriou D. |
Journal | Seizure |
Volume | 94 |
Pagination | 117-125 |
Date Published | 2022 Jan |
ISSN | 1532-2688 |
Keywords | Anticonvulsants, Carbamazepine, Child, Epilepsy, Humans, Levetiracetam, Prevalence, Thyroid Diseases, Valproic Acid |
Abstract | PURPOSE: Antiseizure medications (ASM) have long been examined for their potential to induce thyroid dysfunction. The aim of this systematic review and meta-analysis was to assess the prevalence of thyroid disease in children up to 16 years receiving monotherapy with valproate (VPA), carbamazepine (CBZ) and levetiracetam (LEV). |
DOI | 10.1016/j.seizure.2021.11.010 |
Alternate Journal | Seizure |
PubMed ID | 34896814 |